Public Release:  A recently licensed nicotine receptor stimulant trebles the odds of stopping smoking

Wiley

  • A recently licensed nicotine receptor stimulant trebles the odds of stopping smoking
    The new anti-smoking drug varenicline was first licensed for use in the UK on 5th December 2006. An early Cochrane Review of its effectiveness shows that it can give a three-fold increase in the odds of a person quitting smoking. Varenicline is the first new anti-smoking drug in the last ten years, and only the third, after NRT and bupropion, to be licensed in the USA for smoking cessation.
  • New evidence boosts the conclusion that some antidepressants can double a smoker's chance of quitting
    The most recent Cochrane review concluded antidepressants bupropion (Zyban) and nortriptyline double a person's chances of giving up smoking and have few side-effects, but selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine (Prozac) are not effective.


A recently licensed nicotine receptor stimulant trebles the odds of stopping smoking
The new anti-smoking drug varenicline was first licensed for use in the UK on 5th December 2006. An early Cochrane Review' of its effectiveness shows that it can give a three-fold increase in the odds of a person quitting smoking. Varenicline is the first new anti-smoking drug in the last ten years, and only the third, after NRT and bupropion, to be licensed in the USA for smoking cessation.

People become addicted to smoking tobacco partly because nicotine in the smoke stimulates receptors in the nervous system that cause a release of the feel-good hormone dopamine. Varenicline partially stimulates these nicotine receptors and enables a low-level release of dopamine, which reduces withdrawal symptoms. It also partially blocks nicotine from being absorbed by the receptors, making continued smoking less satisfying. This reduces a person's need to smoke, and may help them to quit completely.

This conclusion was drawn by a group of Cochrane researchers after they studied data from six trials that compared the effects of giving people either varenicline or a placebo. Together the trials involved 2451 people on varenicline and 2473 people on placebos.

Pooling the data showed that people taking varenicline increased their odds of quitting approximately three-fold for 12 months or longer compared with those on placebo drugs .

Data from some of the trials also showed that people given varenicline increased their odds of quitting more than 1½-fold compared with those given bupropion, an antidepressant drug that roughly doubles a person's chance of stopping smoking (see: next press release.)

"What we need now are some trials that make direct comparisons between varenicline and nicotine replacement therapy" says Lead Review Author Kate Cahill, who works in the Department of Primary Health Care at Oxford University.


New evidence boosts the conclusion that some antidepressants can double a smoker's chance of quitting
The most recent Cochrane Review² concluded antidepressants bupropion (Zyban) and nortriptyline double a person's chances of giving up smoking and have few side-effects, but selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine (Prozac) are not effective.

Although nicotine medications are known to help people quit smoking, not everyone is helped by them or wants to use them. One possible alternative is to use antidepressants. The rationale for this is that some people may smoke to combat depression and that stopping smoking could trigger depressive symptoms in some smokers.

A Cochrane review first published in 1997 (and last updated in 2004) showed that the antidepressants bupropion and nortriptyline increase a person's chances of giving up smoking, but selective serotonin reuptake inhibitors such as fluoxetine (Prozac) do not. An updated version of the review published in Jan 2007 now adds 17 more trials to the dataset, and now shows that bupropion and nortriptyline double a person's chance of quitting - again SSRIs have no effect.

"Since bupropion and nortriptyline appear to work as well in non-depressed as depressed persons, this suggests they help smokers quit in some way other than as antidepressants," says John Hughes, a Professor in the Department of Psychiatry at the University of Vermont, Burlington, USA.

###

Notes for editors

  1. 1. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD006103. DOI: 10.1002/14651858.CD006103.pub2.

  2. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD000031. DOI: 10.1002/14651858.CD000031.pub3.

  3. The Cochrane Library contains high quality health care information, including Systematic Reviews from The Cochrane Collaboration. These Reviews bring together research on the effects of health care and are considered the gold standard for determining the relative effectiveness of different interventions. The Cochrane Collaboration (http://www.cochrane.org) is a UK registered international charity and the world's leading producer of systematic Reviews. It has been demonstrated that Cochrane Systematic Reviews are of comparable or better quality and are updated more often than the Reviews published in print journalsª.

  4. The Cochrane Library can be accessed at http://www.thecochranelibrary.com. Guest users may access abstracts for all Reviews in the database, and members of the media may request full access to the contents of the Library. For further information, see contact details below.

  5. A number of countries have national provisions by which some or all of their residents are able to access The Cochrane Library for free. These include:

    Australia www.nicsl.com.au/Cochrane

    All residents of Australia with access to the Internet can access The Cochrane Library for free, thanks to funding provided by the Australian Government and administered by the National Institute of Clinical Studies Denmark www.vifab.dk or www.sundhedsportalen.dk or www.deff.dk or www.cochrane.dk

    All residents of Denmark (including Greenland and the Faroe Islands) can access The Cochrane Library for free, thanks to funding for a national provision from Videns-og Forskningscenter for Alternativ Behandling (ViFAB), Den fælles offentlige sundhedsportal, Biblioteksstyrelsen and The Nordic Cochrane Centre.

    England www.nelh.nhs.uk/cochrane.asp

    All residents of England with access to the Internet can access The Cochrane Library for free, thanks to funding provided by the NHS Connecting for Health, National Library for Health.

    Finland www.terveysportti.fi

    Access to The Cochrane Library is available in Finland for registered users of Terveysportti-portal provided by Duodecim Medical Publications Ltd.

    Ireland All residents within the Island of Ireland can access The Cochrane Library for free, thanks to funding for a national provision by The Health Research Board in Dublin and The Research and Development Office in Belfast.

    Latin and Central America and Carribbean http://cochrane.bireme.br

    All countries in Latin and Central America and Caribbean can access The Cochrane Library for free via the Virtual Health Library BIREME interface (in English, Spanish or Portugues), thanks to funding by BIREME / Pan- American Health Organisation (PAHO) / World Health Organisation (WHO)

    New Zealand http://www.moh.govt.nz/cochranelibrary or http://www.nzgg.org.nz/ or http://www.cochrane.org.nz/

    All residents of New Zealand with access to the internet can access The Cochrane Library for free, thanks to the District Health Boards and the New Zealand Ministry of Health.

    Norway www.cochrane.no

    All residents of Norway can access The Cochrane Library for free, thanks to funding for a national provision from The Norwegian Health Services Research Centre

    Poland http://www.aotm.gov.pl

    All residents of Poland with access to the Internet can access The Cochrane Library for free, thanks to funding for a national provision by Agencja Oceny Technologii Medycznych

    Scotland http://www.nes.scot.nhs.uk/

    All residents of Scotland with access to the Internet can access The Cochrane Library for free, thanks to funding provided by the NHS Education for Scotland

    Spain http://www.update-software.com/Clibplus/ClibPlus.asp

    South Africa http://www.sahealthinfo.org/evidence/databases.htm

    The South African Cochrane Centre (SACC) offers a limited number of free access registrations to The Cochrane Library to African residents. To apply for a sponsorship please register at: http://www.sahealthinfo.org/SAHealthInfoUtils/index.jsp.

    Sweden www.sbu.se

    All residents of Sweden with access to the Internet can access The Cochrane Library for free, thanks to the funding provided SBU - Statens beredning för medicinsk utvärdering/The Swedish Council on Technology Assessment in Health Care

    Wales All residents of Wales with access to the Internet can access The Cochrane Library for free, thanks to funding provided by The Welsh Assembly Government. The Canadian Province of New Brunswick http://www.gnb.ca/0003/

    Access to The Cochrane Library is available for free through the electronic resources section of the NBPLS website to all New Brunswickers who have a public library card thanks to funding provided by the partnership involving the New Brunswick Public Library Service (NBPLS), the University of New Brunswick (UNB) Libraries, and the Regional Health Authority (RHA) libraries

    The Canadian Northwest Territorities, Nunavut, Yukon http://www.thecochranelibrary.com

    All Northern residents with access to the Internet can access The Cochrane Library for free thanks to funding provided by the Pan-Northern Agreement and the Indian and Inuit Branch of Health Canada.

    The Canadian Province of Saskatchewan www.thecochranelibrary.com

    All residents of Saskatchewan can access to The Cochrane Library for free by using public library facilities in the providence and remotely through their local library web site with a library card thanks to funding provided by the partnership involving the Health Quality Council, The Canadian Cochrane Network and Centre (University of Saskatchewan Site Group), the Multitype Database Licensing Program, and the Saskatchewan Provincial Library

    The US State of Wyoming http://wyld.state.wy.us/dbloginform.html/ All residents can access The Cochrane Library for free at the state's Wyoming Libraries Database libraries which include public, community college and medical libraries thanks to funding provided by Wyoming State Legislature's Joint Labor, Health and Social Services Committee

  6. There are also several programmes, such as the Health InterNetwork Access to Research Initiative (HINARI) that provide access in developing countries. To find out whether your country is included in any of these programmes/provisions, or to learn how to get access if you don't already have it, please visit: http://www.thecochranelibrary.com.

If you would like to see a full list of Reviews published in the new issue of The Cochrane Library, or would like to request full access to the contents of The Library, please contact.

Contact: Julia Lampam Tel: +44 (0)1243 770668 Email: jlampam@wiley.co.uk

ª Jadad AR, Cook DJ, Jones A, Klassen TP, Tugwell P, Moher M, et al. Methodology and reports of systematic Reviews and meta-analysies: a comparison of Cochrane Reviews with articles published in paper-based journal.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.